Delisted from NYSE in December 2022
REV - Revlon, Inc.
NYSE
->
Consumer Defensive
->
Household & Personal Products
New York,
United States
Type: Equity
REV price evolution
REV
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $312.5 | $70 | $102.4 | $73.3 |
| Short term investments | ||||
| Net receivables | $285.3 | $337.8 | $383.8 | $391.3 |
| Inventory | $459.7 | $450.6 | $417.4 | $461.5 |
| Total current assets | $1190.2 | $992.3 | $1039.6 | $1058.8 |
| Long term investments | ||||
| Property, plant & equipment | $267 | $291.4 | $297.3 | $305.9 |
| Goodwill & intangible assets | $908.6 | $944.9 | $955 | $964.6 |
| Total noncurrent assets | $1313.5 | $1382.5 | $1392.9 | $1389.4 |
| Total investments | ||||
| Total assets | $2503.7 | $2374.8 | $2432.5 | $2448.2 |
| Current liabilities | ||||
| Accounts payable | $80.6 | $263.7 | $217.7 | $245.6 |
| Deferred revenue | ||||
| Short long term debt | $595.3 | $116.3 | $137.9 | $164.4 |
| Total current liabilities | $969.8 | $795.8 | $787.6 | $810.5 |
| Long term debt | $3667.3 | $3307.1 | $3305.5 | $3302.3 |
| Total noncurrent liabilities | $3882.1 | $3657.6 | $3659 | $3704 |
| Total debt | $4262.6 | $3423.4 | $3443.4 | $3466.7 |
| Total liabilities | $4851.9 | $4453.4 | $4446.6 | $4514.5 |
| Shareholders' equity | ||||
| Retained earnings | -$3181.2 | -$2905.6 | -$2838.6 | -$2848.5 |
| Other shareholder equity | -$231 | -$230.8 | -$234.7 | -$273.4 |
| Total shareholder equity | -$2348.2 | -$2078.6 | -$2014.1 | -$2066.3 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $102.4 | $97.1 | $104.3 | $87.3 |
| Short term investments | ||||
| Net receivables | $383.8 | $352.3 | $423.4 | $431.3 |
| Inventory | $417.4 | $462.6 | $448.4 | $523.2 |
| Total current assets | $1039.6 | $1046.4 | $1111.4 | $1193.8 |
| Long term investments | ||||
| Property, plant & equipment | $297.3 | $352 | $408.6 | $354.5 |
| Goodwill & intangible assets | $955 | $994.5 | $1164.4 | $1205.9 |
| Total noncurrent assets | $1392.9 | $1481.3 | $1869.2 | $1823 |
| Total investments | ||||
| Total assets | $2432.5 | $2527.7 | $2980.6 | $3016.8 |
| Current liabilities | ||||
| Accounts payable | $217.7 | $203.3 | $251.8 | $332.1 |
| Deferred revenue | ||||
| Short long term debt | $137.9 | $220 | $290.2 | $357.4 |
| Total current liabilities | $787.6 | $844.2 | $956.9 | $1120.4 |
| Long term debt | $3305.5 | $3105 | $2906.2 | $2727.7 |
| Total noncurrent liabilities | $3659 | $3545.5 | $3244.9 | $2953.2 |
| Total debt | $3443.4 | $3325 | $3196.4 | $3085.1 |
| Total liabilities | $4446.6 | $4389.7 | $4201.8 | $4073.6 |
| Shareholders' equity | ||||
| Retained earnings | -$2838.6 | -$2631.7 | -$2012.7 | -$1855 |
| Other shareholder equity | -$234.7 | -$277.9 | -$247.4 | -$234.2 |
| Total shareholder equity | -$2014.1 | -$1862 | -$1221.2 | -$1056.8 |
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $442.6 | $479.6 | $615.2 | $521.1 |
| Cost of revenue | $191.4 | $196.9 | $240.4 | $221.2 |
| Gross Profit | $251.2 | $282.7 | $374.8 | $299.9 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $253 | $256.9 | $303.1 | $256.1 |
| Total operating expenses | $685.6 | $339.9 | $382.5 | $347.6 |
| Operating income | -$434.4 | -$57.2 | -$7.7 | -$47.7 |
| Income from continuing operations | ||||
| EBIT | -$218.6 | $4.9 | $56.1 | $15.4 |
| Income tax expense | -$0.5 | $9.8 | -$17.6 | $5.4 |
| Interest expense | $57.5 | $62.1 | $63.8 | $63.1 |
| Net income | ||||
| Net income | -$275.6 | -$67 | $9.9 | -$53.1 |
| Income (for common shares) | -$275.6 | -$67 | $9.9 | -$53.1 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2078.7 | $1904.3 | $2419.6 | $2564.5 |
| Cost of revenue | $849.1 | $860.5 | $1052.2 | $1117 |
| Gross Profit | $1229.6 | $1043.8 | $1367.4 | $1447.5 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1099.1 | $1071.8 | $1316.6 | $1460.5 |
| Total operating expenses | $1430.3 | $1504 | $1532.4 | $1719.3 |
| Operating income | -$200.7 | -$460.2 | -$165 | -$271.8 |
| Income from continuing operations | ||||
| EBIT | $47 | -$216.9 | $39.1 | -$115.4 |
| Income tax expense | $6.2 | $158.8 | $0.2 | $2.2 |
| Interest expense | $247.7 | $243.3 | $196.6 | $176.6 |
| Net income | ||||
| Net income | -$206.9 | -$619 | -$157.7 | -$294.2 |
| Income (for common shares) | -$206.9 | -$619 | -$157.7 | -$294.2 |
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Net income | -$275.6 | -$67 | $9.9 | -$53.1 |
| Operating activities | ||||
| Depreciation | $26.8 | $27.6 | $28.9 | $31.2 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.3 | $1.8 | $3.6 | $3.9 |
| Total cash flows from operations | -$51.2 | $6.7 | $75.7 | -$47.4 |
| Investing activities | ||||
| Capital expenditures | -$2.2 | -$2.3 | -$7.9 | -$3.4 |
| Investments | ||||
| Total cash flows from investing | -$2.2 | -$2.3 | -$7.9 | -$3.4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | $281.8 | -$34.3 | -$38.3 | $15.6 |
| Total cash flows from financing | $281.8 | -$37.6 | -$38.3 | $15.5 |
| Effect of exchange rate | -$2.5 | -$0.1 | -$0.3 | -$1.4 |
| Change in cash and equivalents | $225.9 | -$33.3 | $29.2 | -$36.7 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | -$206.9 | -$619 | -$157.7 | -$294.2 |
| Operating activities | ||||
| Depreciation | $125.7 | $143.3 | $162.9 | $177.2 |
| Business acquisitions & disposals | $2.1 | $31.1 | ||
| Stock-based compensation | $14 | $10.4 | $8.1 | $17.2 |
| Total cash flows from operations | -$11 | -$97.3 | -$68.3 | -$170.8 |
| Investing activities | ||||
| Capital expenditures | -$14.2 | -$10.3 | -$29 | -$57.2 |
| Investments | ||||
| Total cash flows from investing | -$12.1 | -$10.3 | $2.1 | -$57.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | $46.9 | $104.5 | $86.8 | $238.1 |
| Total cash flows from financing | $44.2 | $102.5 | $84.3 | $233.1 |
| Effect of exchange rate | -$2.7 | $3.1 | -$1.1 | -$5 |
| Change in cash and equivalents | $18.4 | -$2 | $17 | $0.1 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 58.57M |
| Revenue | $2.06B |
|---|---|
| EBITDA | -$27.70M |
| EBIT | -$142.20M |
| Net Income | -$385.80M |
| Revenue Q/Q | -11.02% |
| Revenue Y/Y | 0.61% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | -36.15 |
| Cash/Share | 5.34 |
| EPS | -$6.59 |
|---|---|
| ROA | -15.81% |
| ROE | 18.14% |
| Debt/Equity | -2.21 |
|---|---|
| Net debt/EBITDA | -163.88 |
| Current ratio | 1.23 |
| Quick ratio | 0.75 |